› 3usn

Solution NMR

STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE

Released:
DOI: 10.2210/pdb3usn/pdb
PDB entry 3usn coloured by chain, front view.
PDB entry 3usn coloured by chain, side view.
PDB entry 3usn coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Solution structures of stromelysin complexed to thiadiazole inhibitors.
Stockman BJ, Waldon DJ, Gates JA, Scahill TA, Kloosterman DA, Mizsak SA, Jacobsen EJ, Belonga KL, Mitchell MA, Mao B, Petke JD, Goodman L, Powers EA, Ledbetter SR, Kaytes PS, Vogeli G, Marshall VP, Petzold GL, Poorman RA
Protein Sci 7 2281-6 (1998)
PMID: 9827994

Function and Biology Details

Reaction catalysed: 
Preferential cleavage where P1', P2' and P3' are hydrophobic residues.
Biochemical function:
Biological process:
Cellular component:
Sequence domains:
Structure domain:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-140079 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Stromelysin-1 Chain: A
Molecule details ›
Chain: A
Length: 168 amino acids
Theoretical weight: 18.89 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: P08254 (Residues: 100-267; Coverage: 37%)
Gene names: MMP3, STMY1
Sequence domains: Matrixin
Structure domains: Collagenase (Catalytic Domain)

Ligands and Environments

3 bound ligands:
Ligand ZN 2 x ZN
Ligand CA 3 x CA
Ligand ATT 1 x ATT
No modified residues

Experiments and Validation Details

wwPDB Validation report is not available for this NMR entry.
Refinement method: RESTRAINED ENERGY MINIMIZATION AND RESTRAINED MOLECULAR DYNAMICS
Expression system: Escherichia coli

Quick links

Citations

3 review citations

Development of matrix metalloproteinase inhibitors in cancer therapy.
Hidalgo et al. (2001)
2 more